Table 2.
Summary of clinical measures of pain (NRS) and disability (ODI) in all subjects (N = 16), in DH subjects (N = 10), and in Other Dx subjects (N = 6) at pre- and post-treatment
| Clinical outcomes | Pre-treatment | Post-treatment | p value (WSR) |
|---|---|---|---|
| Pain NRS (all subjects) | 9.3 ± 0.9; 10 (9–10) |
5.2 ± 3.4; 5 (2.5–8) |
0.00048 |
| Pain NRS (DH) | 9.5 ± 0.9; 10 (9–10) |
5.5 ± 2.9; 5.5 (2.5–7) |
0.0078 |
| Pain NRS (Other Dx) | 9.0 ± 1.1; 9 (9–10) |
4.8 ± 4.3; 4.8 (0–9) |
0.13 |
| ODI (all subjects) | 45 ± 15; 49 (34–56) |
34 ± 18; 31 (21–52) |
0.064 |
| ODI (DH) | 44 ± 15; 41 (32–52) |
37 ± 16; 38 (26–51) |
0.42 |
| ODI (Other Dx) | 48 ± 15; 54 (48–58) |
30 ± 22; 23 (20–53) |
0.094 |
Data are presented as mean ± standard deviation; median (Q1–Q3), where Q1 and Q3 are the lower and upper quartiles, respectively